joimax^® ANNOUNCES STRATEGIC PARTNERSHIP WITH NAMSA

Taps the market access professionals to oversee reimbursement strategy

IRVINE, CA – joimax^®, the German-based market leader in technologies and training methods for full-endoscopic and minimally-invasive spinal surgery, is pleased to announce a new strategic partnership with NAMSA, the only full continuum Contract Research Organization (CRO) in the world focused exclusively on medical devices. Recognized as a leader in reimbursement strategies, with years of experience in collaborating with public and private payors, Namsa will assist joimax^®’ customers with reimbursement support services, including prior authorization and appeals support, across the United States.

“We are excited for NAMSA to serve as an exclusive partner to help patients access joimax^®’ endoscopic technologies,” stated joimax^® General Manager

Maximilian Ries. “We’re optimistic that with NAMSA’s assistance, and the nearly 5,000 clinical papers on endoscopic spine surgery, we will continue to expand coverage of this important, minimally-invasive technology”.

Since the creation of American Medical Association medical procedural code, CPT^® 62380, Endoscopic Decompression of Neural Elements and/or Excision of Herniated Intervertebral Discs, in 2017, utilization of endoscopic spinal procedures has grown.

For details, visit www.joimax.com.